Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
8.68
+0.79 (10.01%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Vanda Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -220.47 | -18.9 | 2.51 | 6.28 | 33.15 | |
| Depreciation & Amortization | 11.92 | 9.8 | 4.33 | 2.73 | 2.84 | |
| Loss (Gain) From Sale of Investments | -2.05 | -6.99 | -8.14 | -2.96 | 1.64 | |
| Stock-Based Compensation | 9.47 | 12.43 | 14.04 | 16.28 | 15.37 | |
| Other Operating Activities | 83.39 | -5.54 | 0.81 | 3.59 | 8.47 | |
| Change in Accounts Receivable | -7.46 | -13.01 | -0.71 | -1.09 | -2.47 | |
| Change in Inventory | -3.47 | -0.03 | -0.77 | -4.48 | -2.23 | |
| Change in Accounts Payable | 15.82 | 1.71 | -10.98 | 11.79 | 3.04 | |
| Change in Other Net Operating Assets | 3.42 | 4.78 | 11.72 | -0.15 | 4.4 | |
| Operating Cash Flow | -109.44 | -15.76 | 12.8 | 31.98 | 64.21 | |
| Operating Cash Flow Growth | - | - | -59.98% | -50.19% | 24.02% | |
| Capital Expenditures | -1 | -4.72 | -101.05 | -0.68 | -0.55 | |
| Investment in Securities | 95.86 | -12.71 | 88.99 | 50.6 | -76.14 | |
| Investing Cash Flow | 94.86 | -17.43 | -12.06 | 49.93 | -76.7 | |
| Long-Term Debt Repaid | -1.99 | -0.16 | - | - | - | |
| Net Debt Issued (Repaid) | -1.99 | -0.16 | - | - | - | |
| Issuance of Common Stock | - | - | - | 0.73 | 3.55 | |
| Repurchase of Common Stock | -0.92 | - | - | - | - | |
| Financing Cash Flow | -2.91 | -0.16 | - | 0.73 | 3.55 | |
| Foreign Exchange Rate Adjustments | 0.02 | -0.16 | 0.05 | 0.27 | -0.09 | |
| Net Cash Flow | -17.47 | -33.51 | 0.79 | 82.91 | -9.02 | |
| Free Cash Flow | -110.44 | -20.48 | -88.25 | 31.31 | 63.66 | |
| Free Cash Flow Growth | - | - | - | -50.83% | 27.38% | |
| Free Cash Flow Margin | -51.11% | -10.30% | -45.81% | 12.31% | 23.69% | |
| Free Cash Flow Per Share | -1.87 | -0.35 | -1.53 | 0.55 | 1.12 | |
| Cash Income Tax Paid | -0.09 | 2.45 | 3.56 | - | - | |
| Levered Free Cash Flow | -49.36 | -17.05 | -87.45 | 32.34 | 48.22 | |
| Unlevered Free Cash Flow | -49.36 | -17.05 | -87.45 | 32.34 | 48.22 | |
| Change in Working Capital | 8.31 | -6.56 | -0.75 | 6.07 | 2.74 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.